Transaction in Own Shares
Shell (SHEL) reports purchases of its own shares on 29 December 2025 under its existing buy-back programme announced 30 October 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Shell (SHEL) reports purchases of its own shares on 29 December 2025 under its existing buy-back programme announced 30 October 2025. The Company purchased 745,612 shares on the LSE at a volume-weighted average price of £27.1025 and 740,686 shares on XAMS at a volume-weighted average price of €31.1252. These purchases form part of the on- and off-market limbs of the programme, with Merrill Lynch International executing trades independently through to 30 January 2026.
The programme will be conducted in accordance with Chapter 9 of the UK Listing Rules and EU/UK MAR requirements and under the Company’s authorised on- and off-market repurchase authorities.
Positive
- Total shares repurchased: 1,486,298
- LSE purchase: 745,612 shares at VWAP £27.1025
- XAMS purchase: 740,686 shares at VWAP €31.1252
- Execution delegated to Merrill Lynch International through 30 Jan 2026
Negative
- Buyback spend creates cash outflow of ~£20.21m (LSE VWAP × shares)
- Buyback spend creates cash outflow of ~€23.05m (XAMS VWAP × shares)
Details
News Market Reaction – SHEL
On Dec 29, the day this news came out, SHEL closed 0.43% above the previous close.
Data tracked by StockTitan Argus for the Dec 29 session.
Key Figures
- Shares repurchased LSE
- 745,612 shares
- Purchased for cancellation on 29/12/2025 (LSE, GBP)
- VWAP LSE
- GBP 27.1025
- Volume weighted average price on 29/12/2025 LSE buy-back
- Price range LSE
- GBP 26.9500–27.1750
- Lowest and highest prices paid on 29/12/2025 LSE
- Shares repurchased XAMS
- 740,686 shares
- Purchased for cancellation on 29/12/2025 (XAMS, EUR)
- VWAP XAMS
- EUR 31.1252
- Volume weighted average price on 29/12/2025 XAMS buy-back
- Price range XAMS
- EUR 30.9600–31.2400
- Lowest and highest prices paid on 29/12/2025 XAMS
- Programme window
- 30 Oct 2025–30 Jan 2026
- Period during which Merrill Lynch International executes buy-backs
- 52-week range
- USD 58.545–77.47
- Positioned 24.37% above low and 6.02% below high pre-news
Historical Context
-
Disclosure of buy-back purchases on LSE and XAMS for cancellation.
-
PDMRs acquired dividend shares across Amsterdam, London and New York.
-
1,456,156 shares bought and cancelled under ongoing buy-back programme.
-
1,464,165 shares purchased across LSE and XAMS for cancellation.
-
1,967,666 shares repurchased and cancelled in line with buy-back plan.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
volume weighted average price financial
uk listing rules regulatory
eu mar regulatory
uk mar regulatory
off-market buyback contract financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Transaction in Own Shares
29 December, 2025
• • • • • • • • • • • • • • • •
Shell plc (the ‘Company’) announces that on 29 December, 2025 it purchased the following number of Shares for cancellation.
Aggregated information on Shares purchased according to trading venue:
| Date of purchase | Number of Shares purchased | Highest price paid | Lowest price paid | Volume weighted average price paid per share | Venue | Currency |
| 29/12/2025 | 745,612 | 27.1750 | 26.9500 | 27.1025 | LSE | GBP |
| 29/12/2025 | - | - | - | - | Chi-X (CXE) | GBP |
| 29/12/2025 | - | - | - | - | BATS (BXE) | GBP |
| 29/12/2025 | 740,686 | 31.2400 | 30.9600 | 31.1252 | XAMS | EUR |
| 29/12/2025 | - | - | - | - | CBOE DXE | EUR |
| 29/12/2025 | - | - | - | - | TQEX | EUR |
These share purchases form part of the on- and off-market limbs of the Company's existing share buy-back programme previously announced on 30 October 2025.
In respect of this programme, Merrill Lynch International will make trading decisions in relation to the securities independently of the Company for a period from 30 October 2025 up to and including 30 January 2026.
The on-market limb will be effected within certain pre-set parameters and in accordance with the Company’s general authority to repurchase shares on-market. The off-market limb will be effected in accordance with the Company’s general authority to repurchase shares off-market pursuant to the off-market buyback contract approved by its shareholders and the pre-set parameters set out therein. The programme will be conducted in accordance with Chapter 9 of the UK Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes (“EU MAR”) and EU MAR as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time (“UK MAR”) and the Commission Delegated Regulation (EU) 2016/1052 (the “EU MAR Delegated Regulation”) and the EU MAR Delegated Regulation as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time.
In accordance with EU MAR and UK MAR, a breakdown of the individual trades made by Merrill Lynch International on behalf of the Company as a part of the buy-back programme is detailed below.
Enquiries
Media: International +44 (0) 207 934 5550; U.S. and Canada: https://www.shell.us/about-us/news-and-insights/media/submit-an-inquiry.html
Attachment
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.